← Browse by Condition
Medical Condition

renal cell carcinoma clear cell

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06708949 Phase 2
Recruiting

A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)

Enrollment
15 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →